ILA 277.7
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Matricelf Ltd is a biotechnology company that has pioneered a platform dedicated to autologous matrix and cell implants. This advanced regenerative medicine technology is designed to provide therapeutic solutions for a spectrum of challenging medical conditions, such as spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, and also supports innovations in 3D organ printing. Founded in 2019, Matricelf Ltd operates from its base in Ness Ziona, Israel.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Data is available to registered users only